XML 79 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of Current and Deferred Tax Provision
A summary of the Company’s current and deferred tax provision is as follows:
 
 
  
Year Ended December 31,
 
 
  
2021
 
  
2020
 
Current income
tax expense
(benefit):
                 
Federal
 
$
—
 
 
$
—
 
State
     17        17  
    
 
 
    
 
 
 
Total current income tax expense (benefit)
     17        17  
Deferred income tax expense (benefit):
                 
Federal
     1        (2,366 ) 
State
     2        (2,351 ) 
    
 
 
    
 
 
 
Total deferred tax expense (benefit)
    
3
       (4,717 ) 
    
 
 
    
 
 
 
Total (benefit) from income taxes
  
$
20      $ (4,700 ) 
    
 
 
    
 
 
 
Schedule of Reconciliation of the U.S. Federal Statutory Income Tax
A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 
 
  
Year Ended December 31,
 
 
  
2021
 
 
2020
 
Federal statutory income tax rate
     21.0 %       21.0 % 
State income taxes, net of federal benefits
     9.8 %       3.0 % 
Research and development tax credits
     1.5 %       1.0 % 
Interest accretion expense
     8.6 %       5.5 % 
Change in valuation allowance
     (46.1 )%       (21.6 )% 
Mark to market warrant
     2.8        (5.7 )% 
Other permanent items
     2.4
% 
     (1.0 )% 
Effective income tax rate
     (0.0
)
% 
     2.2 % 
    
 
 
    
 
 
 
Schedule of Net Deferred Tax Liabilities
Net deferred tax liabilities as of years ended December 31, 2021 and 2020 consisted of the following:
 
 
  
Year Ended December 31,
 
 
  
2021
 
  
2020
 
Deferred tax assets:
                 
Net operating loss carryforwards
   $ 88,327      $ 53,495  
Research and development tax credit carryforwards
     7,672        5,673  
Stock-based compensation expense
     11,748        1,304  
Startup costs
     697        729  
Intangible assets
     4,471        4,544  
Deferred revenue
     1,103        3,226  
Unicap
     6        6  
Imputed interest on contingent payments
     4,410        2,340  
Legal fee capitalization and amortization
     1,550        1,587  
Other
     1,535        1,158  
    
 
 
    
 
 
 
Total deferred tax assets
     121,519        74,062  
Deferred tax liabilities:
                 
In-process
research and development
     (29,232 )       (27,930 ) 
    
 
 
    
 
 
 
Total deferred tax liabilities
     (29,232 )       (27,930 ) 
    
 
 
    
 
 
 
Valuation allowance
     (92,297 )       (46,139 ) 
    
 
 
    
 
 
 
Net deferred tax liabilities
   $ (10 )     $ (7 ) 
    
 
 
    
 
 
 
Schedule of Unrecognized Tax Benefits
A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:

 
 
  
Unrecognized

Tax Benefits
 
Balance at December 31, 2019
   $ 786  
    
 
 
 
Increase related to prior year tax positions
     —    
Increase related to current year tax provisions
     242  
Decrease for settlements
     —    
Reduction for lapse of applicable statute of limitations
     —    
    
 
 
 
Balance at December 31, 2020
   $ 1,028  
    
 
 
 
Increase related to prior year tax positions
     —    
Increase related to current year tax provisions
    
242

 
Decrease for settlements
     —    
Reduction for lapse of applicable statute of limitations
     —    
    
 
 
 
Balance at December 31, 2021
   $ 1,270